Evolution of cardiac and renal impairment detected by high-field cardiovascular magnetic resonance in mice with renal artery stenosis by Behzad Ebrahimi et al.
Ebrahimi et al. Journal of Cardiovascular Magnetic Resonance 2013, 15:98
http://jcmr-online.com/content/15/1/98RESEARCH Open AccessEvolution of cardiac and renal impairment
detected by high-field cardiovascular magnetic
resonance in mice with renal artery stenosis
Behzad Ebrahimi1, John A Crane1, Bruce E Knudsen2, Slobodan I Macura3, Joseph P Grande2
and Lilach O Lerman1*Abstract
Background: Renal artery stenosis (RAS) promotes hypertension and cardiac dysfunction. The 2-kidney, 1-clip
mouse model in many ways resembles RAS in humans and is amenable for genetic manipulation, but difficult to
evaluate noninvasively. We hypothesized that cardiovascular magnetic resonance (CMR) is capable of detecting
progressive cardiac and renal dysfunction in mice with RAS and monitoring the progression of the disease
longitudinally.
Methods: RAS was induced at baseline in eighteen mice by constricting the renal artery. Nine additional animals
served as normal controls. CMR scans (16.4 T) were performed in all mice one week before and 2 and 4 weeks after
baseline. Renal volumes and hemodynamics were assessed using 3D fast imaging with steady-state precession and
arterial spin labelling, and cardiac function using CMR cine. Renal hypoxia was investigated using blood oxygen-
level dependent (BOLD) MR.
Results: Two weeks after surgery, mean arterial pressure was elevated in RAS mice. The stenotic kidney (STK)
showed atrophy, while the contra-lateral kidney (CLK) showed hypertrophy. Renal blood flow (RBF) and cortical
oxygenation level declined in the STK but remained unchanged in CLK. Moreover, cardiac end-diastolic and stroke
volumes decreased and myocardial mass increased. At 4 weeks, STK RBF remained declined and the STK cortex and
medulla showed development of hypoxia. Additionally, BOLD detected a mild hypoxia in CLK cortex. Cardiac end-
diastolic and stroke volumes remained reduced and left ventricular hypertrophy worsened. Left ventricular filling
velocities (E/A) indicated progression of cardiac dysfunction towards restrictive filling.
Conclusions: CMR detected longitudinal progression of cardiac and renal dysfunction in 2K, 1C mice. These
observations support the use of high-field CMR to obtain useful information regarding chronic cardiac and renal
dysfunction in small animals.
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Cardiovascular disease (CVD) associated with renovas-
cular disease is a major cause of morbidity and mortality
among patients with chronic kidney disease (CKD)
[1-3]. Renal artery stenosis (RAS) is associated with
renin-angiotensin system driven hypertension, which
initiates a cascade of biological events including mechanical* Correspondence: Lerman.Lilach@mayo.edu
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reproduction in any medium, provided the orsignalling, leading to left ventricular (LV) hypertrophy
(LVH) and dysfunction [4,5]. In addition to traditional
causes of CVD such as hypertension, the progression of
CVD may be related to the duration and severity of non-
traditional risk factors, such as renal hypoxia and oxidative
stress [6,7]. This has attracted a great deal of interest to
study the longitudinal association between RAS, renovas-
cular hypertension and CVD, such as LV dysfunction [8].
The two-kidney, one-clip (2K, 1C) model is often used to
induce renovascular hypertension in small animals [9,10].
While many studies were performed in rats, due to theal Ltd. This is an open access article distributed under the terms of the Creative
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cal procedure, in recent years this model has been devel-
oped in mice, mainly due to the possibility of combining
this procedure with genetic manipulations [11-13].
Several imaging modalities can provide important
diagnostic and prognostic insights into cardiac and renal
dysfunction in RAS [14]. In the kidney, renal Doppler
ultrasound is useful to detect and assess renal blood
flow (RBF) [15,16]. Similarly, cardiovascular magnetic
resonance (CMR) is able to evaluate renal volume and
hemodynamics [17-19]. Moreover, blood oxygen-level
dependent (BOLD) MRI has the capacity to non-invasively
measure renal cortical and medullary oxygenation level,
while the only current alternative requires invasive micro-
electrodes [20,21]. Renal hypoxia is an important marker
of progressive kidney dysfunction and contributes to de-
velopment of hypertension [22].
Echocardiography has been extensively used for quanti-
tative LV characterization [23] using important functional
parameters such as LV end-diastolic and end-systolic vol-
umes, ejection fraction, myocardial muscle mass, and early
to late filling velocity ratio (E/A), an index of diastolic
function. Similarly, CMR is capable of assessing cardiac
function and detecting myocardial remodelling [24]. How-
ever, application of cardiac MRI in mice remains limited
mainly due to challenges associated with the temporal and
spatial constrains imposed on clinical CMR systems by the
small size and high heart rate in cardiac imaging of small
animals [25].
Ultra-high field (UHF) MRI has surpassed some limita-
tions of small animal CMR imaging and improved cardiac
imaging in mice [26]. The modality is gaining popularity
owing to its improved sensitivity. Yet, the capability of
UHF-CMR to detect cardiac and renal alterations in vivo
in mice with RAS and follow them longitudinally has not
been explored.
The aim of this study was to determine if UHF-CMR
can non-invasively quantify crucial parameters of cardio-
renal dysfunction and the progression of LV dysfunction
secondary to RAS in 2K, 1C mice model.
Methods
All animal procedures were performed in accordance with
the National Institutes of Health Guide for the Care and
Use of Laboratory Animals, and approved by the Mayo
Clinic Institutional Animal Care and Use Committee.
The study was performed on 27 male 129S1 mice
(Jackson Lab, Bar Harbor, ME). Animals arrived to the
lab at 6 weeks of age, were acclimatized to blood pressure
measurements, and underwent a baseline CMR scan a
week later. Then mice were randomly divided into two
groups. RAS was induced in the first group (n = 18) one
week after the baseline scan by surgical placement of an
arterial cuff. The second group (n = 9) served as thecontrol Normal. All the animals underwent additional
scanning 2 and 4 weeks later.
Surgical procedure
Animals in the RAS group were anesthetized with Isoflur-
ane (1.5-2.0%). The right lateral area between the margin
of the rib cage and thigh was shaved and scrubbed with
povidone-iodine solution. The right kidney was exposed
by a flank incision (~1 cm) and reflected midline. The
right renal artery was then bluntly dissected from the renal
vein between the renal bifurcation and the bifurcation of
the testicular artery. A 0.2 mm ID × 0.5 mm length cuff
(Polyetrafluoroethylene, Braintree Scientific, Braintree, MA)
was cut longitudinally, placed around the renal artery,
and secured with 10-0 nylon suture. Kidney was returned
to its native position and the incisions were sutured as
described [9,27].
Mice were recovered on a warm (37°C) pad until ambu-
latory, and then returned to normal housing with ad libi-
tum access to standard chow and water. Blood pressure
and heart rate were measured before, at 2 weeks and at
4 weeks after baseline by tail-cuff, using a XBP1000 system
(Kent Scientific, Torrington, CT). Animals were eutha-
nized within a day after the 4-weeks scan. The kidneys
and the heart were harvested and fixed for immunohisto-
chemical staining.
Imaging protocol
Imaging was performed on an Avance DRX 700WB
(Bruker-BioSpin, Billerica, MA) spectrometer with a verti-
cal 16.4 T wide bore magnet equipped with mini imaging
accessories. A 38 mm volume RF coil was used for the kid-
ney and cardiac imaging. Mice were mounted vertically
along the magnetic field in a home-made animal holder.
Cardiac and respiratory monitoring and gating were
performed using the Control/Gating Module of Model
1030 Monitoring and Gating System (SA Instruments
Inc., Stony Brook, NY). Body temperature was measured
through a rectal sensor, using temperature module and
maintained at 37°C throughout the course of experiment.
Respiration was measured through a balloon sensor at-
tached to Respiration Module and monitored using the
software provided by SA Instruments. Using 3 planes
(sagittal, coronal and axial), scout images were collected
to locate the heart and kidneys and prescribe the geom-
etry for anatomical and functional imaging.
Renal perfusion and volume were measured in all ani-
mals. Renal blood oxygenation level and cardiac function
were measured in all control animals (n = 9) as well as in
12 of the 18 RAS animals.
The kidney volumes were estimated from images
collected using respiratory-gated 3D Fast Imaging with
Steady Precession (3D-FISP) [28] (TR/TE 14/2.1 ms,
matrix 512×256×128, FOV 5.12×2.56×1.28 cm, flip
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structed into 3-dimensional volumetric images.
Perfusion was measured by arterial spin labelling (ASL)
method [18] using a flow-sensitive Alternating Inversion
Recovery (FAIR) sequence, with Rapid Acquisition with Re-
laxation Enhancement (RARE) (1-2 axial slices per kidney,
with TR/TE 10000/5 ms, RARE factor 72, matrix 128×128,
FOV 4 × 4 cm, slice thickness 1 mm). A total of 22 images
with inversion times of 40 to 2300 ms were collected.
BOLD CMR was applied using respiratory-gated con-
ventional 2-dimensional Multi-Gradient Echo (MGE)
sequence [29] (axial images with 8 echoes (ΔTE = 3 ms)
with TR/TE 200 ms/3.5-24.5 ms, matrix 256×256, FOV
4 × 4 cm, slice thickness 1 mm, flip angle 25°). Global
shimming was performed for all kidneys. In cases of re-
peated failure of the shimming algorithm to converge,
shimming was performed locally.
In some animals (n = 12) BOLD CMR images were also
collected using 3-dimensional MGE to investigate the
feasibility of reducing the effect of the external field
inhomogeneity and susceptibility artefact [30]. The same
FOV as that in conventional BOLD was covered by 16
slices, raising the matrix size to 256×256×16. Then, magni-
tude images of all 16 slices were added to generate a single
1 mm reconstructed image. In improved BOLD, all other
parameters were kept the same as for the conventional
BOLD sequence.
The cardiac cine images were acquired using IntraGate-
Fast Low-Angle Shot (ig-FLASH) sequence [31] (4-6 short
axis slices, TR/TE 3.5/1.45 ms, repetition 100, matrix
256×256, FOV 3.2×3.2 cm, slice thickness 1 mm).
Data analyses
Kidney volumes were calculated from 3D-FISP data using
Analyze™ (Biomedical Imaging Resource, Mayo Clinic,
MN). Corticomedullary borders were evident in the MR
images and used to differentiate cortical and medullary
regions of interest (ROI).
ASL Tool Module (Bruker-ParaVision) was used to
calculate cortical and medullary perfusion in both the
stenotic and contra-lateral kidneys. Blood flow for each
compartment was calculated by multiplying its perfusion
and corresponding volume, and RBF calculated as their
sum.
To calculate the BOLD index, R2* (1/T2*), we took
advantage of the high contrast of cortex and medulla in
ASL images to differentiate the two compartments.
ROIs were drawn on ASL images and then transferred
to all BOLD images corresponding to the 8 echo times.
Voxel-based R2* values were calculated by fitting the
decaying signal of each ROI to a mono-exponential
curve vs. echo times, and cortical and medullary R2*
values by averaging the R2* values for all voxels within
the corresponding ROIs.Cardiac function was calculated from cine images, re-
constructed by Paravision-IntraGate Module. LV myo-
cardial volume was estimated by drawing ROIs around
the outer and inner segments of the myocardium, cal-
culating the difference, and multiplying by the slice
thickness (Simpson’s rule) [32]. The stroke volume was
calculated as the difference of volumes at the end dia-
stolic and systolic phases. The ejection fraction was
assessed by normalizing the stroke volume to the end-
diastolic volume, and cardiac output by multiplication
of the stroke volume and heart rate. The E/A ratios
were calculated from the slopes of the volume-time
curve observed at early (E) and late (A) diastole, utiliz-
ing cardiac images reconstructed at rates of 10, 25 and
40 phases per cardiac cycle using IntraGate module
[33]. The data analysis was performed using Analyze™
and MATLAB® (MathWork, Natick, MA, USA).
Staining
HIF-1α and trichrome were stained on 5-μm axial slides
of tissue using Rabbit polyclonal antigen (Lifespan Biosci-
ences Inc. Seattle, WA) with working dilution of 1:100.
EDTA was used for antigen retrieval.
Statistical analysis
Minimum sample size was calculated using power analysis
for the power value of 0.8. Non-parametric Wilcoxon
signed-rank test was used for comparisons within groups
and Mann-Whitney for comparison among groups. For
p values smaller than 0.05, differences were considered
significant.
Results
Blood pressure measurements at 2-weeks demonstrated
development of renovascular hypertension in RAS. Mean,
systolic, and diastolic blood pressures were significantly
increased in RAS and remained elevated throughout the
study, while control blood pressure remained unchanged
(Table 1). Two weeks after the surgery, RAS animals lost
1.7 ± 0.6 g of their body weight, but regained it by the
fourth week. The control group gained weight during the
course of the study.
Renal volume and function
Two weeks after inducing RAS, the STK cortical and
medullary volumes significantly decreased, and by the
fourth week were on average reduced to 39% and 61% of
their baseline values, respectively (p < 0.001). At 2 weeks,
the CLK cortical volume tended to increase (p = 0.06 vs.
Baseline) and at 4-weeks was significantly elevated com-
pared to both baseline and the control 4-weeks. Medullary
volume remained unchanged during the first 2 weeks, but
at 4 weeks was subsequently diminished compared to the
control group (Figure 1).
Table 1 Blood pressure, renal volumes and hemodynamic
parameters in renal artery stenosis (RAS) or control mice
Baseline 2 weeks 4 weeks
Blood pressure (mmHg)
RAS MAP 80 ± 1 112 ± 5*$# 118 ± 5*$#
Diastolic 72 ± 2 99 ± 4*$# 106 ± 5*$#
Systolic 98 ± 3 138 ± 6*$# 144 ± 6*$#
Control MAP 83 ± 1 78 ± 1 83 ± 3
Diastolic 76 ± 2 69 ± 2 76 ± 4
Systolic 97 ± 2 96 ± 4 99 ± 2
Body weight (g)
RAS 20.7 ± 0.7 19.0 ± 1.2*$# 21.1 ± 1.1#
Control 21.0 ± 0.9 23.2 ± 0.7* 23.8 ± 0.6*
Volume (mm3)
Stenotic Kidney
Cortex 141 ± 8 86 ± 8*$# 91 ± 8*$#
Medulla 47 ± 2 23 ± 4*$# 18 ± 3*$#
Contralateral Kidney
Cortex 140 ± 7 158 ± 7 179 ± 8*$#
Medulla 46 ± 3 42 ± 5 38 ± 3*#
Control
Cortex 135 ± 5 140 ± 3 146 ± 6
Medulla 44 ± 3 42 ± 2 51 ± 3
Flow (μl/min)
Stenotic Kidney
Cortex 613 ± 48 224 ± 35*$# 194 ± 35*$#
Medulla 75 ± 5 24 ± 6*$# 18.0 ± 4*$#
RBF 688 ± 46 248 ± 40*$# 212 ± 39*$#
Contralateral Kidney
Cortex 643 ± 50 650 ± 35 728 ± 52
Medulla 73 ± 4 62 ± 10 55 ± 8#
RBF 716 ± 49 712 ± 41 783 ± 56
Control
Cortex 611 ± 18 680 ± 21 650 ± 35
Medulla 77 ± 5 74 ± 5 83 ± 6
RBF 688 ± 18 754 ± 24* 733 ± 40
Perfusion (ml/100 g/min)
Stenotic Kidney
Cortex 434 ± 22 239 ± 27*$# 194 ± 30*$#
Medulla 168 ± 18 90 ± 11*$# 85 ± 15*$#
Contralateral Kidney
Cortex 458 ± 22 416 ± 16# 409 ± 24
Medulla 165 ± 13 139 ± 13# 134 ± 17
Table 1 Blood pressure, renal volumes and hemodynamic
parameters in renal artery stenosis (RAS) or control mice
(Continued)
Control
Cortex 455 ± 12 487 ± 10 443 ± 14†
Medulla 173 ± 5 176 ± 10 163 ± 6
*P < 0.05 vs. Baseline RAS, $P < 0.05 vs. Baseline Control, †P < 0.05 vs. 2 weeks,
#P < 0.05 vs. Control.
MAP: Mean Arterial Pressure.
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remained lower than Control for the remainder of the
study (p < 0.001). In the CLK, however, cortical blood
flow was preserved, although CLK medullary blood flow
decreased by the fourth week compared to the control.
Control RBF remained unaltered at all time points.
Both medullary and cortical perfusions in the STK were
impaired at two and four weeks (p < 0.001 vs. baselines
and Control), whereas CLK cortical perfusion was not sig-
nificantly changed, but showed strong tendency to decline
during the entire 4 weeks of RAS.
In all the groups BOLD images, acquired using the
conventional method, were highly affected by suscepti-
bility artefacts, particularly in regions adjacent to the
bowel.
In BOLD acquired with the improved method, cortical
R2* in the STK significantly increased (p ≤ 0.02 vs. Base-
line, and p = 0.007 vs. 2-weeks Control) at 2-weeks and
further elevated at 4-weeks (p < 0.001 vs. Baselines and
2-weeks Control, p = 0.004 vs. 2-weeks RAS) (Figure 2).
In contrast, an increase in STK medullary R2* reached
statistical significance only at 4-weeks (p < 0.01 vs. Base-
lines and 4-weeks Control). In the CLK, at 4-weeks cor-
tical oxygenation significantly diminished (p < 0.015 vs.
Baselines and 4-weeks Control) although it was signifi-
cantly higher than in STK. R2* values in the control group
were unchanged.
Cardiac volume and function
In RAS stroke volume and cardiac output decreased at
2 weeks (Table 2), accompanied by myocardial hyper-
trophy (Figure 3A, p < 0.001 vs. Baselines and p = 0.005 vs.
2-weeks Control), while a decrease in LV end-diastolic
volume was only significant compared to the 2-weeks
Control. The control group showed a small increase in
myocardial volume at 4 weeks, whereas ejection fraction
showed no change in any group. At 2-weeks, E/A in RAS,
but not in control, showed a wide range of values. At 4-
weeks RAS E/A increased towards values corresponding
to pseudo normal to restrictive filling phases (p < 0.05 vs.
Baselines and 4-weeks Control) (Figure 3C).
The quality of images deteriorated as the number of re-
constructed phases per cardiac cycle increased. End-
diastolic, end-systolic, and stroke volumes, calculated from
Figure 1 Renal volumes. Axial (left) and coronal (right) cross-sectional MR images of the atrophic stenotic kidney (STK) and hypertrophic contra-
lateral kidney (CLK) 4 weeks after RAS induction (A). Cortical (B), medullary (C) and total renal volumes (D) before, 2 and 4 weeks after RAS
induction or control periods. (*p < 0.05 vs. baseline RAS, $p < 0.05 vs. baseline Control, #p < 0.05 vs. Control).
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slightly (7-11%) albeit not significantly, higher than those
calculated from the set acquired with 10 phases per cycle
(Figure 3B), while the variations in ejection fraction were
negligible. LV volume-time curve analysis showed that (E)
and (A) slopes were not reliably recognizable at 10, but
were detectable in most of the 25 and in all curves with 40
time points per cardiac cycle.
Linear regression (Figure 4) revealed a significant
correlation between cardiac output and CLK cortical
perfusion (R2 = 0.32, p < 0.0001). Additionally, in theSTK cortex volume and oxygenation level correlated
with its perfusion (R2 = 0.24 and R2 = 0.46, respectively,
p ≤ 0.0001).
Renal staining for HIF1-α and trichrome, indices of
tissue hypoxia and fibrosis, demonstrated significantly
higher values in STK vs. CLK at the end of fourth week
(Figure 5).
Discussion
This study demonstrated the feasibility of using UHF-
CMR to longitudinally derive quantitative measures of
Figure 2 Renal BOLD MRI. Blood oxygen level-dependent (BOLD) MRI in the cortex and the medulla of the contra-lateral (left) and stenotic
(right) kidneys, at baseline and 2 and 4 weeks later in RAS and control mice (A-D). Dash-lines show the mean R2* in control animals over the
entire course of study (*p < 0.05 vs. baseline RAS, $p < 0.05 vs. baseline Control, #p < 0.05 vs. control and †p < 0.05 vs. 2-weeks RAS). BOLD maps
acquired using the conventional (E) and the improved (F) BOLD techniques. Severe abdominal susceptibility artefact is evident in the
conventional BOLD map.
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with RAS. The sequential changes in renal and cardiac
function were significant compared to matched con-
trols, and corresponded to the pathophysiology of the
disease.
Two weeks after unilateral RAS, MAP showed signifi-
cant elevation and hemodynamic and morphological
changes were evident. Main renal artery stenosis re-
duces the intra-renal perfusion pressure, which activates
renin-angiotensin-aldosterone system (RAAS) [34]. RAASactivation is often followed by a chain of events, which
eventually result in vascular remodelling and increased
systemic vascular resistance [35]. Concurrently, RAS re-
sults in impaired RBF, decreased oxygen supply, and even-
tually hypoxia, in addition to STK atrophy and reduced
function [4]. Within two weeks, pathophysiological
indices of RAS in the STK included significant renal
atrophy, decreased cortical and medullary perfusion
and RBF, and development of cortical hypoxia, which
correlated with cortical perfusion. Such correlation is
Table 2 Heart rate and left ventricular cardiac parameters
in renal artery stenosis (RAS) or control mice
Baseline 2 weeks 4 weeks
Heart rate (beats per min)
RAS 454 ± 17 429 ± 28 426 ± 19#
Control 470 ± 11 472 ± 3 482 ± 23
Left Ventricular Volume (mm3)
RAS
End Systole 8.4 ± 1.2 9.1 ± 1.5 8.7 ± 1.4
End Diastole 33.2 ± 1.4 30.3 ± 2.0# 29.7 ± 1.7#
Myocardial Volume 53.3 ± 3.7 70.7 ± 3.5*$# 76.6 ± 3.3*$#
Control
End Systole 9.6 ± 1.3 11.2 ± 0.9 11.8 ± 1.3
End Diastole 34.3 ± 2.0 35.9 ± 1.2 36.8 ± 2.4
Myocardial Volume 51.5 ± 0.6 56.6 ± 2.2 61.0 ± 2.2*
Stroke Volume (mm3)
RAS 24.7 ± 1.5 21.1 ± 0.9*$# 20.9 ± 1.3*$#
Control 24.7 ± 1.0 24.8 ± 1.0 24.9 ± 1.5
Ejection Fraction (%)
RAS 74.7 ± 3.0 71.4 ± 3.2 71.3 ± 3.8
Control 72.5 ± 2.6 69.1 ± 1.9 71.4 ± 3.2
Cardiac Output (ml/min)
RAS 11.2 ± 0.7 8.5 ± 0.9*$# 8.7 ± 0.7*$#
Control 11.6 ± 0.4 11.7 ± 0.4 12.7 ± 0.5
E/A Ratio
RAS 1.09 ± 0.08 1.22 ± 0.12 1.40 ± 0.10*$#
Control 1.09 ± 0.04 1.14 ± 0.03 1.11 ± 0.05
Time to Systole/Diastole
RAS 1.2 ± 0.2 1.3 ± 0.2 1.1 ± 0.1
Control 1.1 ± 0.1 1.1 ± 0.1 1.1 ± 0.1
*P < 0.05 vs. Baseline RAS, $P < 0.05 vs. Baseline Control, #P < 0.05 vs. Control.
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oxygen delivery, enhances oxidative stress and promotes
hypoxia.
In the CLK, hypertrophy in the face of unchanged RBF
slightly reduced cortical perfusion. In contrast to the
STK, no correlation was found between cortical perfu-
sion and volume, suggesting that the perfusion decline
in CLK is regulated by factor(s) other than hypertrophy
alone. Previous studies have demonstrated significantly
higher renal vascular resistance in CLK of 2K, 1C rats as
a result of elevated oxidative stress or reduced bioavail-
ability of nitric oxide [36]. In addition, reduced cardiac
output and the increased filtrate volume and swelling of
the CLK tubules might contribute to regional decrease of
perfusion values despite sustained RBF.
LV dysfunction driven by hypertension was also
observed two weeks after RAS induction. Myocardialhypertrophy, initially an adaptive mechanism in re-
sponse to the increased afterload, subsequently evolves
into pathological cardiac remodelling, reducing stroke
volume and cardiac output [37]. Our results indicated
that myocardial mass significantly increased and the
stroke volume decreased, mainly as a result of reduced
LV end-diastolic volume. Cardiac output declined
partly because of the reduced stroke volume and partly
due to the lower heart rate. E/A at 2-weeks demon-
strated substantial variability in the RAS group, ran-
ging from impaired relaxation (low E/A) to restrictive
filling phase (high E/A), indicating large variation in
the rate of the progression and the extent of cardiac
dysfunction among subjects.
By 4 weeks of RAS MAP remained elevated, STK RBF,
perfusion and volume remained impaired, and hypoxia
exacerbated. Conversely, the CLK cortex underwent
further hypertrophy and a mild hypoxia, likely due to
over-functioning as a compensatory mechanism in the
face of slightly declined perfusion that was correlated to
the cardiac output. Yet, R2* values in CLK were signifi-
cantly lower than those in the STK. Histological markers
of tissue hypoxia and fibrosis were greater in the STK
compared to the CLK, confirming BOLD-MRI results and
implying deterioration of the STK structure. In the heart,
despite further hypertrophy of the myocardium, functional
parameters at 4 weeks did not change any further. Never-
theless, high values of E/A became more common, sug-
gesting further progression towards LV restrictive diastolic
dysfunction, concordant with aggravated LVH.
These observations indicate that UHF-CMR allows a de-
tailed characterization of the evolution of cardiac dysfunc-
tion following RAS. In large animal models and clinical
studies, CMR is the reference standard for diagnosis of
cardiac and renal dysfunction. Several studies have dem-
onstrated the accuracy of this modality compared to
ultrasound-based methods [38,39]. Nevertheless, in small
animals, cardiac MRI faces some challenges, such as
small size of the heart and its fast beating, which impose
constrains on spatial and temporal resolutions. Al-
though several recent studies successfully showed the
feasibility of using clinical MR systems for cardiac im-
aging in mice [40,41], the achieved temporal resolutions
remained sub-optimal and lower than typical values ob-
tained with echocardiography and the minimal temporal
resolution required to assess E/A. Our results as well as
others’ [42] show that UHF-CMR affords such high
resolutions.
In addition to cardiac imaging, UHF-CMR was found
to be useful for functional renal MRI. Kidney perfusion
measurement using ASL is rapidly gaining popularity
due to its non-invasive nature. ASL relies on endogen-
ous spin labelled plasma, which carries no physiological
hazard, while an alternative perfusion measurement
Figure 3 Cardiac morphology and function. MRI images of the mouse myocardium at baseline, 2 and 4 weeks after RAS (top) or control (bottom)
(A). Myocardial hypertrophy is evident 2 weeks after renal artery stenosis (RAS). LV volume-time (top) and its slope (bottom) as a measure of filling
velocity (B). The two peaks represent the early (E) and late (A) diastole phase. E/A box plot (*p < 0.05 vs. baseline RAS, $p < 0.05 vs. baseline
Control, #p < 0.05 vs. 4-weeks Control) (C). A schematic illustration of evolution of E/Ain animals with different levels of RAS severity,
demonstrating broad diversity in left ventricular dysfunction during the second week after RAS and greater propensity toward restrictive filling
phase at 4-weeks (D).
Figure 4 Correlations between functional parameters. Correlations between cardiac output and CLK cortical perfusion (A), R2* and perfusion
in the STK cortex (B) and volume and perfusion in the STK cortex (C).
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Figure 5 Renal hypoxia and fibrosis. Colorimetric images (A) and quantification (B) of HIF1-α expression (left) and trichrome (right) as
measures of tissue hypoxia and fibrosis, respectively. HIF1-α and fibrosis expressions were significantly higher in the STK than CLK.
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ministration of potentially nephrotoxicity contrast-media,
particularly in functionally compromised kidneys. To
the best of our knowledge, this is the first study utilizing
ASL with UHF in the kidney. However, previous studies
in other organs have suggested that ASL benefits from
high fields [43,44]. Prolonged T1 and remarkable signal-
to-noise ratio improve the accuracy and sensitivity of
this method, which are particularly important in RAS
kidneys with impaired RBF and intrinsically hypoper-
fused medulla [45].
Yet, the high signal-to-noise ratio in UHF-CMR
comes at the cost of amplified susceptibility artefact,
which particularly affects BOLD images corresponding
to later echoes with longer TE values [46]. Perfect shim
in in-vivo imaging of the abdomen is difficult, and adja-
cency of this organ to the bowel makes this even more
challenging. In our experiments, R2* values calculated
from conventional BOLD maps were highly influenced
by the susceptibility artefact. Therefore, improved
BOLD was employed under the assumption that redu-
cing the thickness and utilizing isotropic voxels would
reduce the phase dispersion caused by the macroscopic
external field inhomogeneity, while the microscopicfield inhomogeneity caused by deoxyhemoglobin would
remain unaffected [30]. Theoretically, the new approach
is more sensitive to blood oxygenation, as tissue con-
trast is solely determined by deoxyhemoglobin concen-
tration rather than modulated heterogeneous tissue
susceptibility. This may also account for the lower R2*
values generally observed in the improved compared to
the conventional BOLD. Nevertheless, because R2* values
are scaled by magnetic field strength, and the values in this
study are considerably higher than those acquired using
clinical MR systems (1.5 and 3 T) [47], or even UHF
systems at lower fields [48].
Our study involved several limitations. Mice reach sex-
ual maturity between 5-8 weeks of age. Body weight, renal,
and myocardial volumes in the control group showed
slight growth during the course the study. Physiological
parameters in the RAS group were compared not only to
their baseline, but also to those in the control group, yet
we cannot rule out the influence of age on the longitudinal
assessments. Furthermore, despite using a similar cuff, the
severity of RAS and the rate of progression of the disease
might not have been identical in all animals, due to intrin-
sic variability. This might have introduced variations in
some of the physiological markers and influenced their
Ebrahimi et al. Journal of Cardiovascular Magnetic Resonance 2013, 15:98 Page 10 of 11
http://jcmr-online.com/content/15/1/98statistical significance. In addition, renal cortical and
medullary volumes were quantified from 3D images with
relatively short echo time, and especially in the STK were
at times difficult to differentiate. Similarly, ASL images
were also less clear in STKs. In the heart, dark regions
caused by ventricular blood vortex, particularly in slices in
the vicinity of the mitral and aortic valves, could have been
mistaken for myocardium and introduced some error into
myocardial mass quantifications. Nevertheless, our mea-
surements were consistent.
Conclusions
Despite potential limitations, UHF-CMR detected
measurable changes in functional and morphological
biomarkers of cardio-renal dysfunction, and afforded a
comprehensive depiction of longitudinal progression of
the disease. Importantly, UHF-MRI, non-invasively, pro-
vided useful information on a broad range of markers of
cardiac and renal dysfunction at higher spatial and tem-
poral resolution than typically achieved using alternative
modalities. These observations support the application
and further development of UHF-MRI for studies of renal
and cardiac function.
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